In addition to Adam Raga’s runner-up finish in the world championship last week, we celebrated Toby Martyn’s title in Trial2. The good results in both categories also allow us to revalidate the constructors’ title for our brand. As for the TDN, Spain won in the women’s and men’s absolute categories, both teams with TRRS riders.
ADAM RAGA, SECOND IN THE PORTUGUESE GP
Positive end of the season for the entire sports structure of TRS Motorcycles. In the top category, Adam Raga was already mathematically assured of the runner-up position, so the excitement was in the fight for victory. On the first lap the sensations were very good and he completed the first pass through the sections in second position, only three points behind the leader.
On the second lap the margin for improvement was not very wide, as the route posed three very difficult sections and he was able to solve one of them, the tenth, cleanly. This allowed him to improve on his previous partial, but he had to settle for second place.
TOBY MARTY TRIAL2 WORLD CHAMPION
In Trial2 we celebrate Toby Martyn’s third position, which allowed him to win the title of the competitive Trial2 category, where this season he has managed to get on the podium on eight of the nine possible occasions, three of them with victory.
The British rider has shown leadership and consistency, achieving a final advantage of fourteen points over the second-placed rider. We also highlight the sixth position of Alex Ferrer, with two podiums to his credit, the last one in this Portuguese GP.
RAGA AND GÓMEZ, TDN CHAMPIONS WITH SPAIN
As for the Trial of Nations, held on Sunday, the Spanish team achieved victory in both the women’s and men’s teams. We celebrate, therefore, the successes of Adam Raga and Sandra Gómez, members of the national team and key riders to reach the crown.
CONSTRUCTORS’ WORLD CHAMPIONS 2021
The great results achieved by the TRS Motorcycles riders allow the brand to add its second consecutive constructors’ title, being also the best two-stroke bike classified in TrialGP and Trial2.
